Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785536 · ClinicalTrials.gov registry record · NA
RITCH: Reducing Disparities in Tobacco Cessation Outcomes
A NA study, sponsored by The City College of New York.
- Completed
- Registry status
- NA
- Development phase
- 256
- Enrollment target
NCT02785536: Completed NA study, sponsored by The City College of New York.
NCT02785536 is a NA study that has completed, run by The City College of New York. The registered enrollment target is 256 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02785536, a NA study, has completed, sponsored by The City College of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 256 participants
- Enrollment target
Study Summary
Tobacco use is a leading contributor to racial and socioeconomic health disparities in the US primarily due to an unequal burden of tobacco-related disease from a disproportionate share of smokers in African American and lower socioeconomic (SES) groups. Unlike many other health risk behaviors, tobacco-related health disparities are increasing despite a large treatment network of free telephone and in-person counseling services, perhaps due to significant disparities in treatment outcomes. The goal of this project is to revise the standard treatment for tobacco dependence to address key factors associated with treatment outcome disparities and more fully meet the needs of lower SES and African American smokers thereby reducing socioeconomic disparities in tobacco dependence treatment outcomes, halting the alarming increase in tobacco-related health disparities, and reducing a leading cause of racial and socioeconomic health disparities in the US.
Primary Outcome
Abstinence will be assessed with latency to relapse (days from Quit Date to relapse or 7 consecutive days of smoking after a 24 hour quit attempt)
Interventions
- BEHAVIORAL Standard Treatment
- BEHAVIORAL RITCh Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 256 participants |
| Start Date | 2013-07 |
| Est. Completion | 2015-06 |
| Phase | NA |
What the finished NCT02785536 record still lists
NCT02785536 is an interventional study that assigns participants to a tested intervention. The registered 256 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Treatment is the first listed.
NCT02785536 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02785536 about?
NCT02785536 is a clinical study titled "RITCH: Reducing Disparities in Tobacco Cessation Outcomes". Tobacco use is a leading contributor to racial and socioeconomic health disparities in the US primarily due to an unequal burden of tobacco-related disease from a disproportionate share of smokers in African American and lower socioeconomic (SES) groups. Unlike many other health risk behaviors, toba...
What is the current status of trial NCT02785536?
This trial is currently completed. It is a NA study. The enrollment target is 256 participants. The study started on 2013-07. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02785536?
The interventions under investigation include: Standard Treatment (BEHAVIORAL), RITCh Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02785536?
This trial is sponsored by The City College of New York, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02785536's enrollment target sits among peer trials
256 404th of 2000 higher than 1,594 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02464696 · 256 participants · NA
Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure
- NCT03793062 · 256 participants
Genetic and Epigenetic Basis of Chronic Wounds
- NCT04322318 · 256 participants · Phase 2
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
- NCT04468360 · 256 participants · Phase 2
Facilitation of Extinction Retention and Reconsolidation Blockade in PTSD
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia